We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Skinbiotherapeutics Plc | LSE:SBTX | London | Ordinary Share | GB00BF33H870 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.11 | 1.20% | 9.25 | 9.00 | 9.50 | 9.25 | 9.25 | 9.25 | 1,064,455 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 132k | -2.84M | -0.0163 | -5.67 | 16.1M |
Date | Subject | Author | Discuss |
---|---|---|---|
15/9/2018 18:47 | Today I watched Cath O'Neill's presentation to investors in Edinburgh. She was asked when the data for the human study will be available and she said likely in the New Year. If I'm honest I thought we would know sooner but patience is required. | gostaa | |
15/9/2018 17:15 | Slarty, Rayrac has just confessed he wouldn't exchange his Ukog for Opti shares, it goes a long to explaining the woeful record in your 2448. I view this as just rewards for one so vile. | incanus | |
14/9/2018 21:39 | A rather awkward query for Raywhack....has SBTX gone up or down since you talked shyte? Has OPTI gone up or down since you talked shyte? Has UKOG gone up since you ramped it? Has BPC gone up or down since you ramped it? Man up and bend the knee and answer? By my calculations, UKOG has lost 80%, BFC lost 75%, SBTX has gained 60% (peak) OPTI gained 100% peak, which means anyone listening to you would potentially have lost 315% of their wealth in a matter of months. The maths look impossible don't they, but you sir are in a league of your own, you actually defy mathematical physics. | slartybartfaster | |
14/9/2018 21:27 | Gostaa has made more sense in 8 posts than Raywhack has in 8,000. Has Gostaa cost anyone any money yet! | slartybartfaster | |
14/9/2018 16:28 | Monday...cho choo....over 30 | costax1654x | |
14/9/2018 16:14 | LOL, Rayrac said invest in BPC and it's since down 72% ??!!! This is gold. | 7ilas | |
14/9/2018 16:06 | Rayrac has a personal vendetta against TW and the poster by the name of Costax. He's not a deramper, he's just very bitter. | gostaa | |
14/9/2018 16:04 | rayrac is the man who told an inexperienced investor to sell sbtx and buy bpc , sbtx up 20% since rayracs advise and bpc down 72% RAYRAC IS A DANGER TO YOUR WEALTH | manc10 | |
14/9/2018 16:02 | Johnson & Johnson certainly see the potential of the microbiome in skincare: | gostaa | |
14/9/2018 15:57 | Excellent interview, there's no doubt the science works, it's a matter of how different cosmetic companies choose to utilise it - cold be a beauty product, anti wrinkle, as well as a moisturiser type cream and almost medical cream to stop skin drying out. lots of different applications and the size of the trial study will give lots of potential info for partners. | deeppockets | |
14/9/2018 15:56 | The Great Rayrac, loser of wealth & fortune, sniffer of glue...has spoken. | 7ilas | |
14/9/2018 15:55 | Success of trial and tie up with Johnson & Johnson will push share price to over 60p. | gostaa | |
14/9/2018 15:54 | Success of trial and tie up with Johnson & Johnson will push share price to over 60p. | gostaa | |
14/9/2018 15:48 | Load of nonsense, proof of it working is not available nor will it be! | rayrac | |
14/9/2018 15:44 | Second RNS with Results....50+? | costax1654x | |
14/9/2018 15:43 | 33,37,44 targets here before and after first RNS | costax1654x | |
14/9/2018 15:26 | Looking very good here guys. Well done! | parob | |
14/9/2018 15:16 | Just bought more! | 7ilas | |
14/9/2018 15:10 | Latest presentation from CEO Cath O'Neill at Shares and AJ Bell Investor Evening in Edinburgh is now available - | 7ilas | |
14/9/2018 14:45 | https://www.youtube. | costax1654x | |
14/9/2018 12:48 | I think you are talking about Chung! | costax1654x |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions